Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7321 - 7328 of 12016 results
URGENT UPDATE: Executive Order Travel Ban Lifted – At Least Temporarily
February 4, 2017| Alert| Viewpoint
Upcoming Event: EUCI's U.S./Canada Cross-Border Energy Trade Summit
February 3, 2017| Blog| Viewpoint
Supreme Court set to Decide this Term if Employees Can Waive Their Right to Bring a Class or Collective Action
February 3, 2017| Blog| Viewpoint
California Update: Amended Civil Code Section 1938 and New CASp Obligations for Commercial Landlords
February 2, 2017| Alert| Viewpoint
Updated Guidance on the Implementation of the Travel Ban Executive Order
February 2, 2017| Alert| Viewpoint
The Groundhog Says Six More Weeks of Winter, So Employers Should Remain Mindful of Their Obligations During Inclement Weather
February 2, 2017| Blog| Viewpoint
It’s Tax Time – Don’t be Phished
February 2, 2017| Blog| Viewpoint
Target Data Breach Deal's Hiccup Puts Focus On Standing
February 2, 2017| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|